Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shandong Sino-Agri United Biotechnology Co (003042) Fair Value & Analysis

Basic Materials · CN · Market cap 1.9B CNY

Price¥13.19
Fair Value¥3.22
Upside-75.6%
Quality95/100
Evidence: Low Range ¥1.32 – ¥5.12

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Shandong Sino-Agri United Biotechnology Co (003042) currently trades at ¥13.19, while our model-based Fair Value estimate is ¥3.22 — implying the stock looks roughly 75.6% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. The company's products include imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. It also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. Shandong Sino-Agri United Biotechnology Co.,Ltd was founded in 2006 and is based in Jinan, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Shandong Sino-Agri United Biotechnology Co (003042) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥3.22 versus a price of ¥13.19 — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 003042?
Our 21-model fair value for Shandong Sino-Agri United Biotechnology Co is ¥3.22 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥13.19.
What is the quality score of 003042?
Shandong Sino-Agri United Biotechnology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.